1. Cancer Statistics, 2020;Siegel,2020
2. Boo, D.Q.A., et al.., Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment – Sci. Direct. 229.
3. Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells;Grieco;J. Cell. Biochem.,2011
4. 68Ga-PSMA-PET/CT in Comparison With 18F-fluoride-PET/CT and Whole-body MRI for the Detection of Bone Metastases in Patients With Prostate Cancer: A Prospective Diagnostic Accuracy Study;Eva,2018
5. Distribution of Metastatic Sites in Patients With Prostate Cancer: A Population-based Analysis;Gandaglia,2014